Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Genetic epidemiology and insights into interactive genetic and environmental effects in autism spectrum disorders.
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial.
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey.
Transient frictional slip between integrin and the ECM in focal adhesions under myosin II tension.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Transient frictional slip between integrin and the ECM in focal adhesions under myosin II tension.
Transient frictional slip between integrin and the ECM in focal adhesions under myosin II tension. Curr Biol. 2010 Jul 13; 20(13):1145-53.
View in:
PubMed
subject areas
Extracellular Matrix
Focal Adhesions
Humans
Integrins
Myosin Type II
authors with profiles
Margaret L. Gardel